X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (70) 70
life sciences & biomedicine (61) 61
humans (60) 60
medicin och hälsovetenskap (37) 37
risk factors (37) 37
medical and health sciences (36) 36
female (28) 28
male (27) 27
cardiovascular disease (26) 26
middle aged (26) 26
cardiovascular system & cardiology (23) 23
genome-wide association study (23) 23
abridged index medicus (22) 22
aged (22) 22
polymorphism, single nucleotide (22) 22
klinisk medicin (21) 21
stroke (21) 21
clinical medicine (20) 20
genetics (20) 20
stroke - genetics (20) 20
genomes (18) 18
genetic predisposition to disease (17) 17
genotype (17) 17
medical genetics (17) 17
research (17) 17
studies (17) 17
cardiac & cardiovascular systems (16) 16
neurology (16) 16
adult (14) 14
clinical neurology (14) 14
coronary heart disease (14) 14
genetic aspects (14) 14
medicinsk genetik (14) 14
neurosciences & neurology (14) 14
cardiovascular diseases (13) 13
genetics & heredity (13) 13
lipids (13) 13
peripheral vascular disease (13) 13
basic medicine (12) 12
cholesterol (12) 12
coronary artery disease - genetics (12) 12
heart diseases (12) 12
medicine (12) 12
medicinska och farmaceutiska grundvetenskaper (12) 12
meta-analysis (12) 12
atherosclerosis (11) 11
case-control studies (11) 11
general & internal medicine (11) 11
genomics (11) 11
medicine, general & internal (11) 11
neurologi (11) 11
phenotype (11) 11
brain ischemia - genetics (10) 10
lipoproteins (10) 10
aged, 80 and over (9) 9
analysis (9) 9
epidemiology (9) 9
genes (9) 9
genetic variation (9) 9
kardiologi (9) 9
medical research (9) 9
cardiac and cardiovascular systems (8) 8
cholesterol, ldl - blood (8) 8
coronary artery disease (8) 8
coronary disease - genetics (8) 8
european continental ancestry group - genetics (8) 8
genetic research (8) 8
genome-wide association study - methods (8) 8
heart attacks (8) 8
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (8) 8
multidisciplinary sciences (8) 8
polymorphism, single nucleotide - genetics (8) 8
science & technology - other topics (8) 8
statins (8) 8
clinical trials (7) 7
coronary artery (7) 7
endocrinology and diabetes (7) 7
endokrinologi och diabetes (7) 7
genetic association studies (7) 7
health risks (7) 7
incidence (7) 7
physiological aspects (7) 7
plasma (7) 7
stroke - epidemiology (7) 7
cardiovascular diseases - genetics (6) 6
consortia (6) 6
coronary disease - epidemiology (6) 6
coronary vessels (6) 6
gene expression (6) 6
gene frequency (6) 6
genetic loci (6) 6
genetic loci - genetics (6) 6
health aspects (6) 6
internal medicine (6) 6
ldl-cholesterol (6) 6
loci (6) 6
low density lipoprotein (6) 6
medicine, experimental (6) 6
mendelian randomization analysis (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS medicine, ISSN 1549-1676, 02/2012, Volume 9, Issue 2, pp. e1001177 - e1001177
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2009, Volume 361, Issue 26, pp. 2518 - 2528
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2017, Volume 377, Issue 13, pp. 1217 - 1227
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2014, Volume 371, Issue 3, pp. 203 - 212
Adults with vascular disease were treated with a statin to lower LDL cholesterol and were assigned to receive either extended-release niacin plus laropiprant... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Male | Hypercholesterolemia - drug therapy | Indoles - administration & dosage | Infection - chemically induced | Niacin - administration & dosage | Treatment Failure | Musculoskeletal Diseases - chemically induced | Niacin - adverse effects | Cholesterol, LDL - blood | Female | Hypolipidemic Agents - adverse effects | Atherosclerosis - drug therapy | Double-Blind Method | Risk Factors | Indoles - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hypolipidemic Agents - administration & dosage | Diabetes Mellitus - chemically induced | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Drug Combinations | Dose-response relationship (Biochemistry) | Laropiprant | Blood circulation disorders | Care and treatment | Dosage and administration | Niacin | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Heart attacks | Risk groups | Diabetes mellitus | Cardiovascular disease | Low density lipoprotein | Cholesterol | Musculoskeletal system | Vascular diseases | Arteriosclerosis | Vitamin B | Skin | Lipoproteins (high density) | Drug dosages | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Nature (London), ISSN 1476-4687, 08/2013, Volume 502, Issue 7471, pp. 377 - 380
Journal Article